Home
About
Overview
Sharing Data
ORCID
Help
History (261)
2020: Gene Therapy Enters Its Fourth Decade.
InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions.
Novel marine phenazines as potential cancer chemopreventive and anti-inflammatory agents.
Airway management in pediatric patients at referring hospitals compared to a receiving tertiary pediatric ICU.
Cellular senescence offers distinct immunological vulnerabilities in cancer.
See All 261 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cellular senescence offers distinct immunological vulnerabilities in cancer.
Zhou L, Ma B, Ruscetti M. Cellular senescence offers distinct immunological vulnerabilities in cancer. Trends Cancer. 2025 Apr; 11(4):334-350.
View in:
PubMed
subject areas
Animals
Cellular Senescence
Humans
Immunotherapy
Neoplasms
T-Lymphocytes
Tumor Escape
Tumor Microenvironment
authors with profiles
Marcus Ruscetti PhD